Chen Lin, Wei Zhiliang, Chan Kannie Wy, Li Yuguo, Suchal Kapil, Bi Sheng, Huang Jianpan, Xu Xiang, Wong Philip C, Lu Hanzhang, van Zijl Peter Cm, Li Tong, Xu Jiadi
F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, MD, USA.
Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
J Cereb Blood Flow Metab. 2021 May;41(5):1013-1025. doi: 10.1177/0271678X20941264. Epub 2020 Jul 16.
In this study, we applied on-resonance variable delay multiple pulse (onVDMP) MRI to study D-glucose uptake in a mouse model of Alzheimer's disease (AD) tauopathy and demonstrated its feasibility in discriminating AD mice from wild-type mice. The D-glucose uptake in the cortex of AD mice (1.70 ± 1.33%) was significantly reduced compared to that of wild-type mice (5.42 ± 0.70%, = 0.0051). Also, a slower D-glucose uptake rate was found in the cerebrospinal fluid (CSF) of AD mice (0.08 ± 0.01 min) compared to their wild-type counterpart (0.56 ± 0.1 min, < 0.001), which suggests the presence of an impaired glucose transporter on both blood-brain and blood-CSF barriers of these AD mice. Clearance of D-glucose was observed in the CSF of wild-type mice but not AD mice, which suggests dysfunction of the glymphatic system in the AD mice. The results in this study indicate that onVDMP MRI could be a cost-effective and widely available method for simultaneously evaluating glucose transporter and glymphatic function of AD. This study also suggests that tau protein affects the D-glucose uptake and glymphatic impairment in AD at a time point preceding neurofibrillary tangle pathology.
在本研究中,我们应用共振可变延迟多脉冲(onVDMP)磁共振成像(MRI)来研究阿尔茨海默病(AD)tau蛋白病小鼠模型中的D-葡萄糖摄取,并证明其在区分AD小鼠和野生型小鼠方面的可行性。与野生型小鼠(5.42±0.70%)相比,AD小鼠皮质中的D-葡萄糖摄取(1.70±1.33%)显著降低(P=0.0051)。此外,与野生型小鼠(0.56±0.1分钟)相比,AD小鼠脑脊液(CSF)中的D-葡萄糖摄取速率较慢(0.08±0.01分钟,P<0.001),这表明这些AD小鼠的血脑屏障和血脑脊液屏障上存在葡萄糖转运体受损。在野生型小鼠的脑脊液中观察到了D-葡萄糖的清除,但在AD小鼠中未观察到,这表明AD小鼠的类淋巴系统功能障碍。本研究结果表明,onVDMP MRI可能是一种经济高效且广泛可用的方法,用于同时评估AD的葡萄糖转运体和类淋巴功能。本研究还表明,tau蛋白在神经纤维缠结病理之前的时间点影响AD中的D-葡萄糖摄取和类淋巴损伤。